Markets

Market Nav

News Details

06/05/2024 11:20

Indo US Bio-Tech Q2 net profit up 28.46% at Rs 1.67 cr

The company reported standalone net profit of Rs 1.67 crore for the quarter ended September 30, 2023 as compared to Rs 1.30 crore in the same period last year, registering a year-on-year growth of 28.46 per cent.

Net revenue of the company rose moderately by 14.98 per cent at Rs 15.81 crore in July-September quarter of this fiscal as against Rs 13.75 crore in the corresponding period last year.

During July-September quarter, operating expenses increased by 12.41 per cent to Rs 13.22 crore from Rs 11.76 crore in year ago period.

Operating Profit surged by 30.15 per cent to Rs 2.59 crore as against Rs 1.99 crore in the year ago period, while Operating Profit Margin (OPM) expanded year-on-year to 13.57 per cent in September quarter.

Interest grew by 86.36 per cent y-o-y to Rs 0.41 crore, while Taxation increased by 0.00 per cent at Rs 0.30 crore (Sep'22 Rs 0.30 crore).